Showing results (3901-3910 of 5,101) with videos related to
Sort By:
Pageof 511
Health Science Reports|October 10, 2022
Kidney stones among Iranian adults: Prevalence and socioeconomic inequality assessment in a cohort-based cross-sectional studyTelma Zahirian Moghadam, Farhad Pourfarzi, Hamed Mohseni Rad, et al.Health Science Reports|September 29, 2022
Multistep screening and selection of COVID-19 convalescent plasma donors at the early stage of the SARS-CoV-2 pandemic: A retrospective analysisAndreas M Brosig, Thomas Ossner, Irene Pamler, et al.Health Science Reports|September 29, 2022
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approachCarmen Angioletti, Egidio de Mattia, Luca M Carloni, et al.Health Science Reports|October 3, 2022
Point of care prehospital ultrasound in Basic Emergency Services in PortugalManuel José Cruz Duarte Lobo, Sérgio Carlos Castanheira Nunes Miravent Tavares, Rui Pedro Pereira de AlmeidaHealth Science Reports|August 29, 2022
Standardized reporting of amnion and amnion/chorion allograft data for wound careTaylor J Sabol, Grace S Tran, Jason Matuszewski, et al.Health Science Reports|September 30, 2022
Neutrophil-to-lymphocyte ratio as a predictor of clinical outcomes in critically ill COVID-19 patients: A retrospective observational studyHusain S Ali, Dore C Ananthegowda, Ebrahim M A Ebrahim, et al.Health Science Reports|January 6, 2022
Role of neutrophil to lymphocyte ratio as a prognostic indicator for COVID-19Samar A Amer, Omar A Albeladi, Arafa M Elshabrawy, et al.Health Science Reports|May 4, 2019
Predictors of in-hospital mortality after ischemic stroke: A prospective, single-center studyIzaro Kortazar-Zubizarreta, Ana Pinedo-Brochado, Itxaso Azkune-Calle, et al.Health Science Reports|May 4, 2019
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative diseaseYang Yang, Xiaoyan Han, Gaofeng Zheng, et al.Health Science Reports|May 4, 2019
Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practiceAnnick Desjardins, James E Herndon, Frances McSherry, et al.Pageof 511